Lab Mission
Maternity morbidity is increasing, and prenatal care has drastically increased in complexity. Outcomes are rooted in social determinants of health and driven by substance use disorders, emerging new infections, and other challenging co-morbidities, requiring interdisciplinary expertise. The Kelly Research Team investigates innovative models of care in these challenging spaces to improve healthcare access and treatment success.
Jeannie Kelly, MD, MS
Associate Professor, Obstetrics and GynecologyDivision of Maternal-Fetal Medicine
Medical Director, Maternal-Fetal Transport
Primary Methods
- Prospective cohorts studies during pregnancy and postpartum
- Mixed-methods and implementation science; Randomized controlled trials
Ongoing Studies
OPIOID BPP: Using longitudinal, advanced diffusion magnetic imaging techniques throughout pregnancy to determine the impact of prenatal opioid exposure on placental inflammation and hypoxia, fetal brain dysmaturation, neural injury, and neonatal neurodevelopment. (Dr. Yong Wang)
PATCH BRIDGE: Prospective, mixed-methods study to evaluate the feasibility of conducting a randomized controlled trial comparing buprenorphine transdermal bridge induction versus standard sublingual induction in pregnant patients with opioid use disorder
STOP-COVID: Prospective cohort study determining optimal testing and vaccination strategies for COVID-19 during pregnancy to inform prenatal care and improve vaccine counseling.
Why a career in research?
The gap – between available treatments to optimize outcomes and the ability of patients to access them – is far too wide for most patients we serve. I am driven to find evidence-based solutions that can close this gap efficiently and effectively.
Dr. Kelly
Contact
Email – jckelly@wustl.edu